Omvoh Side Effects
Generic name: mirikizumab
Medically reviewed by Drugs.com. Last updated on Jun 13, 2024.
Note: This document provides detailed information about Omvoh Side Effects associated with mirikizumab. Some dosage forms listed on this page may not apply specifically to the brand name Omvoh.
Applies to mirikizumab: solution.
Serious side effects of Omvoh
Along with its needed effects, mirikizumab (the active ingredient contained in Omvoh) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking mirikizumab:
More common side effects
- body aches or pain
- chills
- cough
- diarrhea
- ear congestion
- fever
- headache
- loss of taste or smell
- loss of voice
- muscle pain
- nausea or vomiting
- sneezing
- sore throat
- stuffy or runny nose
- trouble breathing
- unusual tiredness or weakness
Less common side effects
- burning or stinging of the skin
- painful blisters on the trunk of body
- painful cold sores or blisters on the lips, nose, eyes, or genitals
Incidence not known
- chest tightness
- dark urine
- difficulty swallowing
- fast heartbeat
- hives, itching, skin rash
- loss of appetite
- lower back or side pain
- painful or difficult urination
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- stomach pain, severe
- yellow eyes or skin
Other side effects of Omvoh
Some side effects of mirikizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common side effects
- bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
Less common side effects
- difficulty in moving
- joint pain
- muscle pain or stiffness
For healthcare professionals
Applies to mirikizumab: intravenous solution, subcutaneous solution.
General adverse events
The most common adverse reactions reported are upper respiratory tract infection, headache, rash, and injection site reactions.[Ref]
Cardiovascular
- Common (1% to 10%): Hypertension[Ref]
Dermatologic
- Common (1% to 10%): Rash[Ref]
Rash included macular rash, maculopapular rash, pruritic rash, and popular rash.[Ref]
Gastrointestinal
- Common (1% to 10%): Ulcerative colitis, abdominal pain, diarrhea, gastroesophageal reflux disease
- Frequency not reported: Intestinal sepsis[Ref]
Hematologic
- Common (1% to 10%): Anemia[Ref]
Hepatic
- Uncommon (0.1% to 1%): Increased AST, increased ALT[Ref]
Immunologic
- Very common (10% or more): Anti-drug antibodies (up to 23%)[Ref]
Local
- Common (1% to 10%): Injection site reactions[Ref]
Injection site reactions included erythema, hypersensitivity, pain, reaction, and urticaria at the injection site.[Ref]
Musculoskeletal
- Common (1% to 10%): Arthralgia[Ref]
Nervous system
- Common (1% to 10%): Headache[Ref]
Other
- Common (1% to 10%): Herpes viral infection, pyrexia, increased blood creatine phosphokinase, fatigue
- Frequency not reported: Listeria sepsis[Ref]
Herpes viral infection included herpes zoster, herpes simplex, and oral herpes.[Ref]
Respiratory
- Very common (10% or more): Upper respiratory tract infections (up to 14%)
- Frequency not reported: Pneumonia[Ref]
Upper respiratory tract infections included COVID-19, nasopharyngitis, pharyngitis, rhinitis, oropharyngeal discomfort, oropharyngeal pain, tonsillitis, viral upper respiratory tract infection, acute sinusitis, and sinusitis.[Ref]
References
1. (2023) "Product Information. Omvoh (mirikizumab)." Lilly, Eli and Company, 1.0
2. (2023) "Product Information. Omvoh (mirikizumab)." Eli Lilly and Company Ltd
3. (2023) "Product Information. Omvoh (mirikizumab)." Eli Lilly Australia Pty Ltd
More about Omvoh (mirikizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Omvoh side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.